caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1972618338

Danielle FoggNP

Nurse PractitionerBrewer, MEI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Danielle Fogg's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 16 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Penobscot Community Health Center
Clinic or Group Practice · Bangor, ME
3373
Corey Couto
Diagnostic Radiology · Bangor, ME
2745
Ellen Arey
Nurse Practitioner · Brewer, ME
2647
PILOTTE, JANICE2538
Guillermo Olivos
Diagnostic Radiology · Bangor, ME
2546
Scott Dufresne
Pathology · Pittsburgh, PA
2370
ST. JOSEPH HOSPITAL2378
AFFILIATED LABORATORY, INC.2269
PORTER, DIANA1936
Benjamin Bamford
Diagnostic Radiology · Bangor, ME
1728
SEBASTICOOK VALLEY HEALTH1353
Audrey Garrett
Hematology-Oncology · Brewer, ME
1357
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
261
Unique beneficiaries
—
Total services
379
Distinct HCPCS
2
Medicare payment
$25K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,197 Nurse Practitioner providers in ME — top quintile (cohort median 175).
PRESCRIBING · PART D · 2024
Total Rx claims
829
Beneficiaries
—
Total drug cost
$777K
Distinct drugs
33
Brand share
22.0%
Top prescribed drugs
Letrozole79 claims
Anastrozole61 claims
Dexamethasone59 claims
Apixaban41 claims
Ondansetron Hcl40 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
84.1
Quality
64.8
Cost
68.9
Improvement activities
40.0
Promoting interop.
96.0
Payment adjustment
0.38%
Group